NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Jul 10, 2013
Insider Transaction Report
Form 4
Shea Thomas
SVP Manufacturing Operations
Transactions
- Sale
Common Stock
2013-07-08$14.34/sh−7,000$100,380→ 13,071 total - Exercise/Conversion
Common Stock
2013-07-08$4.32/sh+5,000$21,600→ 20,071 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-07-08−5,000→ 80,000 totalExercise: $4.32From: 2009-03-31Exp: 2015-03-30→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2013.
- [F2]This stock option vests as to 25% of the underlying shares on March 31, 2009 and then in 36 equal monthly installments thereafter.